Verition Fund Management
AZN icon

Verition Fund Management’s AstraZeneca AZN Stock Holding History

Verition Fund Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,589
Closed -$476K – 2339
2025
Q4 		$476K Sell
2,589
-692
-21% -$121K ﹤0.01% 2695
2025
Q3 		$503K Sell
3,281
-7,897
-71% -$1.2M ﹤0.01% 3026
2025
Q2 		$1.56M Buy
11,178
+5,539
+98% +$776K 0.01% 2136
2025
Q1 		$829K Buy
5,639
+2,859
+103% +$414K ﹤0.01% 2263
2024
Q4 		$364K Buy
2,780
+611
+28% +$85.5K ﹤0.01% 2663
2024
Q3 		$338K Sell
2,169
-4,202
-66% -$678K ﹤0.01% 2563
2024
Q2 		$994K Buy
6,371
+27
+0.4% +$4.06K 0.01% 1677
2024
Q1 		$860K Sell
6,344
-2,401
-27% -$318K 0.01% 1703
2023
Q4 		$1.18M Buy
+8,745
New +$1.14M 0.01% 1093
2023
Q1 		– Sell
-285,144
Closed -$38.7M – 2152
2022
Q4 		$38.7M Hold
285,144
– – 0.6% 17
2022
Q3 		$31.3M Buy
285,144
+283,575
+18,074% +$36M 0.35% 37
2022
Q2 		$207K Sell
1,569
-1,871
-54% -$245K ﹤0.01% 1924
2022
Q1 		$456K Sell
3,440
-64,060
-95% -$7.68M 0.01% 1950
2021
Q4 		$7.86M Sell
67,500
-1,268,601
-95% -$149M 0.06% 221
2021
Q3 		$160M Buy
1,336,101
+680,741
+104% +$79.2M 1.39% 10
2021
Q2 		$78.5M Buy
655,360
+605,396
+1,212% +$66.4M 0.71% 27
2021
Q1 		$4.97M Sell
49,964
-144,473
-74% -$14.5M 0.06% 200
2020
Q4 		$19.4M Buy
194,437
+77,315
+66% +$8.19M 0.17% 89
2020
Q3 		$12.8M Buy
117,122
+114,250
+3,978% +$12.7M 0.26% 67
2020
Q2 		$304K Buy
+2,872
New +$297K 0.01% 789
2020
Q1 		– Sell
-440,905
Closed -$44M – 613
2019
Q4 		$44M Buy
440,905
+414,274
+1,556% +$39M 0.8% 25
2019
Q3 		$2.37M Buy
+26,631
New +$2.31M 0.07% 209
2013
Q3 		– Sell
-5,572
Closed -$264K – 536
2013
Q2 		$264K Buy
+5,572
New +$284K 0.05% 393

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Verition Fund Management's AZN Position: Q1 2026 in Review

Verition Fund Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 2,589 shares — an estimated $476K sold.

Verition Fund Management first reported a position in AZN in Q2 2013 and held it in 23 quarters. The position peaked at $160M in Q3 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Verition Fund Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 2,589 AstraZeneca shares in Q1 2026, an estimated $476K.
  • Verition Fund Management first reported a position in AstraZeneca in Q2 2013 and held it in 23 quarters.
  • Verition Fund Management's AstraZeneca position peaked at $160M in Q3 2021.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.